Boston Scientific (BSX) announced on Wednesday the acquisition of the ~74% stake in Bolt Medical that the medical devices ...

Boston Scientific initially developed the concept for the Bolt IVL system, which is engineered to fracture calcium using ...

Boston Scientific Corporation (NYSE:BSX) agreed to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy ...

Boston Scientific stock popped Wednesday after the medtech giant agreed to full acquire Bolt Medical for up to $900 million.

The deal for Bolt, developer of an intravascular lithotripsy system to treat coronary and peripheral artery disease, ...

Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular lithotripsy (IVL) platform developer ...

The biomedical and biotech engineering firm will acquire another development company specializing in cardiovascular disease ...

Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire Bolt Medical, the developer of an intravascular ...

Boston Scientific is diving into the field of intravascular lithotripsy, with a $664 million deal to pick up Bolt Medical and ...

Boston Scientific Corp. (BSX) announced on Wednesday its agreement to acquire the remaining 74 percent stake in Bolt Medical, Inc., ...

Boston Scientific has agreed to acquire the rest of Bolt Medical, the developer of an intravascular-lithotripsy, or IVL, laser-based platform for the treatment of coronary and peripheral artery ...

Acquisition Strengthens Boston Scientific's Position in Minimally Invasive Treatment for Coronary Artery Disease ...